© Copyright 2025 American Medical Association. All rights reserved.
Short Descr | IDH1 IDH2&TERT PROMOTER NGS | Medium Descr | IDH1 IDH2&TERT PROMOTER CNS TUMORS NGS S/D/I | Long Descr | IDH1 (isocitrate dehydrogenase 1 [NADP+]), IDH2 (isocitrate dehydrogenase 2 [NADP+]), and TERT (telomerase reverse transcriptase) promoter (eg, central nervous system [CNS] tumors), next-generation sequencing (single-nucleotide variants [SNV], deletions, and insertions) | CLIA Waived (QW) | No | APC Status Indicator | Service Paid under Fee Schedule or Payment System other than OPPS | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. |
Date
|
Action
|
Notes
|
---|---|---|
2025-01-01 | Added | First appearance in codebook. |
2024-10-01 | Added | Code added |
Get instant expert-level medical coding assistance.